Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14336109 | 1.00 | ALOX5 (0.33) | ALOX5SMYD3DPP4 | |
| SCHEMBL8227849 | 1.00 | ALOX5 (0.33) | ALOX5SMYD3DPP4 | |
| SCHEMBL4938530 | 1.00 | ALOX5 (0.33) | ALOX5SMYD3DPP4 | |
| SCHEMBL13775302 | 1.00 | ALOX5 (0.33) | ALOX5SMYD3DPP4 | |
| SCHEMBL18987904 | 1.00 | ALOX5 (0.33) | ALOX5SMYD3DPP4 | |
| Hydrochloric Acid SCHEMBL18988009 | 0.97 | ALOX5 (0.32) | ALOX5SMYD3DPP4 | |
| Hydrochloric Acid SCHEMBL18988007 | 0.97 | ALOX5 (0.32) | ALOX5SMYD3DPP4 | |
| Hydrochloric Acid SCHEMBL4933747 | 0.97 | ALOX5 (0.32) | ALOX5SMYD3DPP4 | |
| Hydrochloric Acid SCHEMBL21222289 | 0.97 | ALOX5 (0.32) | ALOX5SMYD3DPP4 | |
| Hydrochloric Acid SCHEMBL4933740 | 0.97 | ALOX5 (0.32) | ALOX5SMYD3DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431323-A | Heterobicyclic amides as CD38 inhibitors | 贝林格尔·英格海姆国际有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-114423753-B | Heterobicyclic amides as CD38 inhibitors | 里邦医疗公司 | 2024-09-17 | — | — | CN | disclosed |
| EP-4003980-A1 | HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38 | Ribon Therapeutics Inc. (US) | 2022-06-01 | — | — | EP | disclosed |
| CN-114423753-A | Heterobicyclic amides as CD38 inhibitors | 里邦医疗公司 | 2022-04-29 | — | — | CN | disclosed |